October 4th 2024
Dr. Wagner discusses her work with the Bill and Melinda Gates Medical Research Institute.
Chasing Breakthroughs in I&I: Pfizer’s Mike Gladstone
May 11th 2021Mike Gladstone, Pfizer’s Global President of Inflammation & Immunology (I&I), talks about how the company is addressing the unmet need in I&I and how its relationships with patients is fueling the quest for breakthroughs over ‘me too’ incremental improvements
Sam Pearce: Joining the Jigsaw Pieces at Jazz
February 1st 2021Sam Pearce, SVP, Head of Europe and International at Jazz Pharmaceuticals, talks about joining the company during a transformative period and how she is working to foster a bold and collaborative culture to expand Jazz’s footprint in Europe and beyond.
Hooked on Gene Therapy: Kevin Foust, Novartis
December 22nd 2020Kevin Foust, Senior Director of Research & Early Development at Novartis Gene Therapies, talks to Pharm Exec about his involvement in the development of Zolgensma, the first and only gene therapy approved to treat spinal muscular atrophy (SMA).